Koers MustGrow Biologics Corp. Canadian Securities Exchange
Aandelen
MGRO
CA62822A1030
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CAD | -.--% | +6,74% | -28,57% |
Omzet 2022 | 6,48K 4,72K 4,42K | Omzet 2023 | 4,71 mln. 3,44 mln. 3,22 mln. | Marktkapitalisatie | 66,39 mln. 48,41 mln. 45,3 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -5 mln. -3,65 mln. -3,41 mln. | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | 26.167 x |
Nettoliquiditeiten 2022 | 6,26 mln. 4,56 mln. 4,27 mln. | Nettoliquiditeiten 2023 | 6,06 mln. 4,42 mln. 4,13 mln. | EV/omzet 2023 | 12,8 x |
K/w-verhouding 2022 |
-31,2
x | K/w-verhouding 2023 |
-95,1
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 88,6% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Corey Giasson
CEO | Chief Executive Officer | 46 | 15-03-18 |
Todd Lahti
DFI | Director of Finance/CFO | 58 | 17-12-18 |
Colin Bletsky
COO | Chief Operating Officer | 49 | 15-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Brian Quigley
BRD | Director/Board Member | 50 | 17-07-19 |
Brad Munro
CHM | Chairman | 64 | 15-03-18 |
Corey Giasson
CEO | Chief Executive Officer | 46 | 15-03-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,13% | 43,43 mld. | |
+48,60% | 41,69 mld. | |
+8,49% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+8,26% | 25,28 mld. | |
-23,69% | 18,47 mld. | |
+32,83% | 12,59 mld. | |
+1,58% | 12,33 mld. | |
+6,63% | 11,03 mld. |
- Beurs
- Aandelen
- Koers MGRO
- Koers MGRO